Pericardial Dysfunction Postoperative Cardiac Surgery

Total Page:16

File Type:pdf, Size:1020Kb

Pericardial Dysfunction Postoperative Cardiac Surgery An Exploration of Issues Associated with Pericardial Dysfunction in Postoperative Cardiac Surgery Patients Glenda Pack, RN, NP, MN, CCCN(C), CCN(C) Dynamics 2013 Nurse Practitioner, CV Surgery September 23/13 Eastern Health, St. John’s, Newfoundland Review the anatomy and pathophysiology associated with conditions involving the pericardium Explore the trajectory of pericardial dysfunction Assist the nurse to hone assessment skills to detect pericardial dysfunction Review historical and current treatment methodologies Approach to Excising Approach to Closing Open Improved hemodynamics in the early phase Decreased incidence of graft failure ? Reduced incidence of cardiac tamponade Closed Protective from sternal adhesions in redo-operations Might not have control over how the pericardium is handled, but knowing how it was handled is important for patient management Pericardial Effusion Excess accumulation of fluid in the pericardium May or may not be clinically significant Pericarditis Inflammation of the Cardiac Tamponade pericardium Pericardial Effusion that causes significant compression of the heart Acute Latent PPtost-PPiericardi ditotomy Synd rome 70 yo male POD #1 CABG x3 Chest tubes removed 3 hours ago Complaining of vague chest discomfort Unable to take a deep breath Pericardial friction rub LSB POD #! Inflammation of the pericardium CV patient Idiopathic Direct and/or indirect trauma Benign and self limiting Diagnosis Treatment ECG Relieve Symptoms Symptoms Analgesics Friction rub NSAIDs Corticosteriods Colchicine Symptomatic treatment Monitor for development of pericardial effusions Monitor for development of Post- Pericardiotomyyy Syndrome Prior to transfer from CVICU was started on Ibuprofen 400mg tid x 24 hours POD # 2 creatine had increased from 90 to 140 Ibuprofen D/C EKG POD#3: POD #3 Incidence as high as 85% in post-operative CV patients Insult to pericardium Manifestations dependant on the rate of fluid accumulation Many undetected /Transient / Benign Maximum size POD #10 – regress after 30% are quantified are “large” ~ 1% of larggppe effusions develop tamponade Diagnosis Treatment ECG None CXR NSAIDs TTE* Corticosteriods TEE Colchicine CT Pericardiocentesis MRI Oppgen Surgical Draina ge Supportive (usually self limiting) Monitoring for signs of decreasing cardiac output malaise, orthopnea, fatigue, dyspnea, unexplained tachycardia, hypotension, Hemodynamically pulses paradoxus, jugular venous Significant? distension, distant heart sounds, ascites, peripheral edema, progressive azotemia, gradual equalization of R atrial, PAD and wedge pressures, mediastinal widening on CXR Worsening Effusion Possibly prepare for pericardiocentesis Monitoring for decompensation post pericardiocentesis Possibly prepare for re-sternotomy Mr. S 70 year old male elective admission for Bentall Procedure Normal coronary arteries GdGrade 2 LVF on cath Bicuspid AV 3+ AI Dilated aortic root and ascending aorta Chronic Atrial Fib – On coumadin, stopped x 7/7 bridged with Lovenox ppgytt slightly elevated / remained of coa gs OK HT N Exsmoker (x 20yrs) Single presyncopal episode 8 yrs ago Experiencing increasing dyspnea OR • Bentall procedure with #27 Carbomedics Mechanical Prosthesis / #30 Valsava graft • Pericardium was closed with 2.0 silk • Total operating time 4.25 hours • Transported to CVICU in critical condition POST-OP • Uncomplicated • Trans ferre d to Car diac Spec ia l Care unit POD #1 A pericardial effusion that causes significant compression of the heart Rare, but life- Rare, but life-threatening threatening SCHIAVONE W A Cleveland Clinic Journal of Medicine 2013;80:109-116 Within 5-7 dayyps post cardiac surg er y 0.1% - 6% As a resul t of post-oper ati ve bleed in g Limited expansion of the pericardium Low pressure tamponade / regional tamponade because of loculated effusions & localized pericardial adhesions Fluid accumulation (and therefore pressure) in the pericar dium compresses the myocardildial tissue and bldblood is not able to propel forward Cardiogenic shock Know who is at risk Bleeding Pre-oppg(g) risk of bleeding (medications, bleeding hx) Hemodilution (excessive I/V fluids, prolonged pump run) HhiHypothermia Serum lab values (platelets, hgb, azotemia) Heparin rebound Post epicardial pacing wire removal Greater than 7 dayyggys following surgery –up to 1 year (30-45 days) Higher mortality rate than Early Tamponade Almost exclusively patients who have had valve surgery IdIncreased iiidncidence excessive INR values As a result of Fluid (blood /exudate) Air (pneumopericardium) Lyyp(mph (chyyplopericardium) Later that day..... (POD#1) When ambulating pre-syncopal, hypotensive eppgisode.... Recovered.....vital signs and labs stable . Over the next few days Mr. S was slow to ambulate, vital signs were stable, developed increasing peripheral edema, rhythm atrial fib wit h v. rate 100-110/ min POD#6 – still not right.. Stable.. Echo • Normal functioning Bentall with Aortic Valve functioning • LVH • Dildlated LV wit hbdlh borderline impairment o f systo lic function • Small to moderate ppjyericardial effusion with the majority of fluid located posteriorly without hemodynamic effect POD #8 – decreasing B/P , Temp increased, WBC increase to 17, lower sternum unstbltable, stlternal drainage, CXR- bilateral pleural effusions Monitoring Vital signs (HR, B/P) EKG changg(es (tachy / low voltagg)e) Mental status Leftward deviation of PA catheter on CXR Chest tube losses Sudden large volume – bleeding Sudden slowing – clotting Classic Signs Monitoring ? Pulses Paradox Decreased systolic upstoke on arterial pressure monitor SBP drop greater than 10mmHg between expiration and inspiration ElitiEqualization of the R artilterial pressure and PCWP Pulses Paradoxus Suppressed: •LV dysfunction •Regional tamponade •PPV •COPD with cor pulmonal e •Severe AI •Intracardiac shunt Quiet heart sounds Beck’s triad High JVP Low arterial pressure Distended neck veins Dx – Cardiac Tamponade - Late … ? Early too and mechanical sternal dehiscence Returned to OR for medistinal Re-exploration with the evacuation of a large pericardial effusion – relief of tamponade, drainage of bilateral pleural effusions, and sternal rewiring. Mr. S was discharged 12days later Intra op cultures were negative Follow up echo Valve fn N/ no pericardial effusion noted / CXR N EARLY Re-sternotomy to determine and alleviate the source of bleeding Support hemodynamics Correct coagulopathies Correct hypothermia Decrease metabolic demands LATE Periocardiocentesis (when possible) Re-sternotomy unable to tolerate echo failure of percutaneous drainage presence of intrapericardial hematoma Mr. B. 62 yo male with bicuspid aortic valve with critical aortic stenosis Elective admission for AVR Aortic Valve Replacement with #27 St. Jude Mechanical Prosthesis Uncomplicated post-operative course Discharge home on POD#5 On coumadin with therapeutic INR 2.5 Common complication of cardiac surgery Occurs a few days–weeks (even months) after cardiac surggyery Incidence 10-40% Prolonging and disabling Immune-mediated inflammatory process Mild(isolated pleural/pericardial involvement) to severe (hemodynamic consequences) Presentation Post cardiac surgery Pericarditis Pericardial rub Fever Leukocytosis Increased sed rate Pulmonary infiltrates +/- pleural effusion 2 weeks followinggg() discharge (POD#19) Mr. B presented to his community hospital with increasing shortness of breath, low grade fever and sign ifican t L pleura l effus ion Transferred to tertiary hospital: CXR – Large L pleural effusion TTE – Mod sized pericardial effusion without comprise - N functioning mechanical aortic valve prosthesis No vegetation INR erratic control noted by his family physician L chest tube – drained 2 liters sero-sang drainage Placed on prednisone Discharged home 3 days after CT discontinued Diagnosis Fever without alternative causes Pleuritic chest pain Friction rub Evidence of pleural effusion Evidence of a new or worsening pericardial effusion Imazio et al. propose the presence of at least 2 of these criteria for diagnosis of PPS International Journal of Cardiology 159(2012) 1-4 Management Diagnostics Treatment Echo Anti-inflammatory agents Corticosteriods CT Thoracentesis Prevention – Colchicine shown to be safe and effective Decreased occurrence of chest pppain and pleural effusions (COPPS &COPPS2 trials) 3 weeks later Mr. B ppyresented to his community hospital with increasing dyspnea Increased JVP Increased WBC Transferred to tertiary facility again - CCU CXR - Mod L pleural effusion Echo - Large pericardial effusion CT – drained L pleural effusion PiPeriocar diocentes is – large effiffusion diddrained Discharggpe home on prednisone –no further readmissions CV patients do not follow classic pictures of disease symptomatology There can be a significant delay in post- oppperative complications Manyyg signs of pericardial d ysfunction are masked by post-operative pain and “expected” recovery symptoms (fatigue / dyspnea) Low threshold for performing an echo in CV patient with atypical symptoms Pericardial dysfunction is often benign and transient, but an index of suspicion needs to be maintained when patients are not progressing just as expected ? Role of colchcine .
Recommended publications
  • Bentall Procedure: Quarter Century of Clinical Experiences of a Single
    Benke et al. Journal of Cardiothoracic Surgery (2016) 11:19 DOI 10.1186/s13019-016-0418-y RESEARCHARTICLE Open Access Bentall procedure: quarter century of clinical experiences of a single surgeon Kálmán Benke1,3*, Bence Ágg1,3, Lilla Szabó1, Bálint Szilveszter1,4, Balázs Odler2, Miklós Pólos1, Chun Cao1, Pál Maurovich-Horvat1,4, Tamás Radovits1, Béla Merkely1 and Zoltán Szabolcs1,3 Abstract Background: We retrospectively analyzed 25 years of experiences with the button Bentall procedure in patients with aortic root pathologies. Even though this procedure has become widespread, there are only a few very long term follow-ups available in the clinical literature, especially regarding single surgeon results. Methods: Between 1988 and 2013, a total of 147 patients underwent the Bentall procedure by the same surgeon. Among them there were 62 patients with Marfan syndrome. At the time of the surgery the mean age was 46.5 ± 17.6 years. The impact of surgical experience on long-term survival was evaluated using a cumulative sum analysis chart. Results: The Kaplan-Meier estimated overall survival rates for the 147 patients were 91.8 ± 2.3 %, 84.3 ± 3.1 %, 76.3 ± 4.9 % and 59.5 ± 10.7 % at 1,5,10 and 20 years, respectively. Multivariate Cox regression analysis identified EuroSCORE II over 3 % (OR 4.245, 95 % CI, 1.739–10.364, p = 0.002), acute indication (OR 2.942, 95 % CI, 1.158–7.480, p = 0.023), use of deep hypothermic circulatory arrest (OR 3.267, 95 % CI, 1.283–8.323, p = 0.013), chronic kidney disease (OR 6.865, 95 % CI, 1.339–35.189, p = 0.021) and early complication (OR 3.134, 95 % CI, 1.246–7.883, p = 0.015) as significant risk factors for the late overall death.
    [Show full text]
  • Selected Terms Used in Adult Congenital Heart Disease Jack M
    SELECTED TERMS USED IN ADULT CONGENITAL HEART DISEASE JACK M. COLMAN | ERWIN NOTKER OECHSLIN | MATTHIAS GREUTMANN | DANIEL TOBLER ambiguus A With reference to cardiac situs, neither right nor left sided aberrant innominate artery (indeterminate). Latin spelling is generally used for situs ambig- A rare abnormality associated with right aortic arch compris- uus. Syn: ambiguous sidedness. See also situs. ing a sequence of arteries arising from the aortic arch—right carotid artery, right subclavian artery, and then (left) innomi- Amplatzer device nate artery—with the last passing behind the esophagus. This A group of self-centering devices delivered percutaneously by is in contrast to the general rule that the first arch artery gives catheter for closure of abnormal intracardiac and vascular con- rise to the carotid artery contralateral to the side of the aortic nections such as secundum atrial septal defect, patent foramen arch (ie, right carotid artery in left aortic arch and left carotid ovale or patent ductus arteriosus. artery in right aortic arch). Syn: retroesophageal innominate artery. Anderson-Fabry disease See Fabry disease aberrant subclavian artery Right subclavian artery arising from the aorta distal to the left aneurysm of sinus of Valsalva subclavian artery. Left aortic arch with (retroesophageal) aber- See sinus of Valsalva/aneurysm. rant right subclavian artery is the most common aortic arch anomaly. It was first described in 1735 by Hunauld and occurs anomalous pulmonary venous connection in 0.5% of the general population. Syn: lusorian artery. See also Pulmonary venous connection to the right side of the heart, vascular ring. which may be total or partial.
    [Show full text]
  • THÈSE DE DOCTORAT DE « Clémentine SHAO »
    THÈSE DE DOCTORAT DE L’UNIVERSITE DE RENNES 1 COMUE UNIVERSITE BRETAGNE LOIRE Ecole Doctorale N°601 Mathématique et Sciences et Technologies de l’Information et de la Communication Spécialité : Signal, Image, Vision Par « Clémentine SHAO » « Images and models for decision support in aortic dissection surgery » «Images et modèles pour l’aide à la décision clinique de la chirurgie de la dissection aortique» Thèse présentée et soutenue à RENNES , le 16/12/19 Unité de recherche : LTSI, Inserm U1099 Thèse N° : Rapporteurs avant soutenance : Frans Van De Vosse, PR, Eindhoven University of Technology (TU/e), Netherlands Alain Lalande, MCU-PH, Université de Bourgogne Franche-Comté, France Composition du jury : Président : Examinateurs : Alain Lalande, MCU-PH, Université de Bourgogne Franche-Comté, France Nadjia Kachenoura, CR INSERM, Sorbonne Universités, France Frans Van De Vosse, PR, Eindhoven University of Technology (TU/e), Netherlands Jean-Philippe Verhoye, PU-PH, CHU de Rennes, France Dir. de thèse : Pascal Haigron, PR, Université de Rennes 1, France Co-dir. de thèse : Gabriele Dubini, PR, Politecnico di Milano, Italie Invité(s) Michel Rochette, Directeur Technique, Ansys France, France ACKNOWLEDGEMENT Je tiens à remercier I would like to thank. my parents.. J’adresse également toute ma reconnaissance à .... .... i LIST OF ABBREVIATIONS AA Ascending Aorta AD Aortic Dissection BC Boundary Condition BT Brachiocephalic Trunk CFD Computational Fluid Dynamics CT Computed Tomography CVS Cardiovascular System DA Descending Aorta DOE Design Of Experiment
    [Show full text]
  • Table of Contents Introduction
    Congenital Heart Surgery Database v.3.3 effective July 1, 2015 Training Manual October 2017 Table of Contents Introduction ................................................................................................................................................................2 1. Administrative ...............................................................................................................................................2 2. Demographics ...............................................................................................................................................5 3. Noncardiac Congenital Anatomic Abnormalities ....................................................................................... 21 4. Chromosomal Abnormalities ..................................................................................................................... 22 5. Syndromes ................................................................................................................................................. 23 6. Hospitalization ........................................................................................................................................... 24 7. Preoperative Factors .................................................................................................................................. 28 8. Diagnosis .................................................................................................................................................... 30 9. Procedures ................................................................................................................................................
    [Show full text]
  • Eighteen Years of Clinical Experience with a Modification of the Bentall Button Technique for Total Root Replacement
    6741 Original Article Eighteen years of clinical experience with a modification of the Bentall button technique for total root replacement Dimos Karangelis, Dimitrios Tzertzemelis, Alexandros A. Demis, Stella Economidou, Matthew Panagiotou Cardiac Surgery Department, Athens Medical Center, Distomou 5, Amaroussio 151 25, Greece Contributions: (I) Conception and design: D Karangelis, M Panagiotou; (II) Administrative support: S Economidou, M Panagiotou; (III) Provision of study materials or patients: D Tzertzemelis, AA Demis; (IV) Collection and assembly of data: D Tzertzemelis, AA Demis; (V) Data analysis and interpretation: D Karangelis, D Tzertzemelis, S Economidou; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Matthew Panagiotou, MD, FECTS. Cardiac Surgery Department, Athens Medical Center, Distomou 5, Amaroussio 151 25, Greece. Email: [email protected]. Background: We retrospectively reviewed our experience with the modified Bentall procedure and evaluated the short- and long-term results over a period of 18 years. Methods: Between 1999 and 2017, 89 patients with a mean age of 57.3±13.9 years underwent the modified Bentall operation with a slight modification for the correction of aortic root disease. Results: The operative mortality was 1.1% while the overall early mortality rate, defined as death within 30 days of initial hospitalization, was 2.2% (2/89). Logistic regression analysis revealed that increased Euroscore and aortic cross-clamp times were associated with greater likelihood for complications. The overall survival rates for the 89 patients (including deaths occurred at the initial hospitalization) were 93.0% (SE =3.0%) at 6 months, 93.0% (SE =3.0%) at 1 year, 89% (SE =5.0%) at 5 years and 73.0% (SE =5.0%) at 10, 15 and 18 years.
    [Show full text]
  • Case Report Bentall Surgery for Acute Aortic Dissection
    KYAMC Journal Vol. 9, No.2, July 2018 Case Report Bentall surgery for acute aortic dissection (type-a) in a patient with marfan syndrome Mohammad Arifur Rahman1, Md. Lutfar Rahman2, Prakash Chandra Munshi3, Taslim Yusuf Tamal4, Mejbaur Rahman5, Mehedi Hassan Romel6, Joyanta Kumar Saha7, Mohammad Quamruzzaman8 Abstract Background: Marfan syndrome is an autosomal-dominant hereditary connective tissue disorder with the clinical manifestations involving the ocular, skeletal, and cardiovascular systems. The cardiovascular manifestations include aortic root dilatation, aortic valvular insufficiency, mitral valve prolapse, mitral regurgitation, aortic dissection and aortic rupture. Acute aortic dissection is one of the most common catastrophes involving the aorta. A high index of suspicion is important in patients who have predisposing risk factors. Classification is based on the location of dissection and its duration. Stanford type A (De bakey type I /type II) dissection should be treated surgically in essentially all cases. Objective: To report our experience in Bentall surgery in Acute aortic dissection (type A ). The efficacy of right axillary artery cannulation was investigated. Materials & Methods: Patient with acute type A aortic dissection involving coronary sinuses with 3 vessels of the arch free of lesions underwent aortic valve with ascending aorta and hemiarch replacement with composite valve graft (Bentall procedure) and reimplantation of coronary arteries under moderate hypothermia. The axillary artery was used for arterial cannulation. Results: Weaning from CPB was smooth. Perioperative period was eventless. Follow-up Echo revealed normal cardiac parameters. Conclusion: Prompt establishment of the diagnosis, through focused physical examination and noninvasive imaging, followed by rapid medical and surgical therapy, are the only effective methods to alter survival in patients with acute aortic dissection.
    [Show full text]
  • Clinician Update Feb
    Clinician Update Feb. 4, 2021 Countdown to the Cures Act: Virtua’s Release Set for Feb. 23 The date is now set. On Tuesday, Feb. 23, in accordance with the federally mandated 21st Century Cures Act, Virtua plans to begin immediate electronic release of all inpatient and outpatient clinical results to the patient’s MyChart account. The Cures Act will bring major changes in how health information is delivered and shared, giving patients greater access and control through full and immediate access to their record, as well as their ability to share that record for whom they give authorization. We support this policy toward the goal of achieving the best outcomes for our patients. The Cures Act will require readiness on all our parts. Virtua is working diligently to support our clinicians through this dramatic shift in data management. We will continue to provide updates and are planning future opportunities for education. Remember, we have a Cures Act resource section available to all Virtua clinicians on Digital 411. In the coming days, we will continue to update content with tip sheets and resource documents. Feel free to direct any questions to [email protected]. Case Summaries Highlight Virtua’s CT Surgery Capabilities At a recent cardiovascular services summit, council leads shared updates and achievements that demonstrate the comprehensive nature of Virtua’s heart program. Each of the sections, including congestive heart failure, clinical cardiology, interventional cardiology, heart rhythm, and structural heart, as well as cardiothoracic surgery, were represented. Case reviews highlighted the expertise of several clinical sections, including the following presented on behalf of the cardiac surgery program by Arthur Martella, MD, Chief of Cardiothoracic Surgery at Virtua: • Dr.
    [Show full text]
  • Copyrighted Material
    Index Note: Page numbers in italics refer to Figures; those in bold to Tables. activated clotting time (ACT), 35–9 interrupted aortic arch, 121 Blalock–Taussig shunt (BTS), 95, 114, Alfieri stitch, 172 luminal variation, 24, 25 115, 117, 129, 142, 149, 152, 155, alpha-stat blood gas management see placement, 79–80 159, 173, 177, 180 blood gas management regional perfusion strategies, 52–4, 115 blood coagulation see anticoagulation anomalous aortic origin of a coronary arterial decannulation, inadvertent, 73, management artery (AAOCA), 88 170 blood gas management anomalous left coronary artery from the arterial head occlusion, 29–30 alpha-stat management, 40–44 pulmonary artery (ALCAPA), 86 arterial line filters (ALF) on bypass, 80–81 anticoagulation management blood flow path, 13, 13 oxygenation strategy, 42–4 activated clotting time (ACT), 35–9 external, 12, 12, 13, 14, 61–2 pH-stat management, 40–44 blood coagulation pathways, 35, 35, 36 integral, 5–8, 9 blood pressure management coagulation factors, 35, 35 arterial pump failure (roller head), 164 cardiopulmonary bypass, 47–8 heparin concentration management, 37 arterial switch operation (ASO), 85, 112, cerebral blood flow (CBF), 47 prime volume 140, 141, 174–7 see also Jatene higher than expected, 148 circuit exposure, 36 procedure lower than expected, 149 examples, 14, 187, 188 arterio venous MUF (AVMUF), 56–9, 57 ranges, 48, 48 oxygenator primes, 5–8 atrial line, 77 blood prime see also priming procoagulant factors, 35, 36 placement, 82 blood volume, 31, 31 protamine dosing, 38–9
    [Show full text]
  • Fate of the Coronary Ostial and Distal Aortic Anastomoses After Modified Bentall’S Operation (UKC’S Modification)
    Chowdhury UK, George N, Singh S, Hasija S, Sankhyan LK, Sharma S, Pandey NN, Sengupta S, Kalaivani M. Fate of the Coronary Ostial and Distal Aortic Anastomoses after Modified Bentall’s Operation (UKC’s Modification). J Surg & Journal of Surgical Tech.2020;2(1):11-20 Surgery and Surgical Technology Original Research Article Open Access Fate of the Coronary Ostial and Distal Aortic Anastomoses after Modified Bentall’s Operation (UKC’s Modification) Ujjwal K. Chowdhury1*, Niwin George1, Sukhjeet Singh1, Suruchi Hasija2, Lakshmikumari Sankhyan1, Srikant Sharma1, Niraj Nirmal Pandey3, Sanjoy Sengupta1, Mani Kalaivani4 1Departments of Cardiothoracic and Vascular Surgery, All India Institute of Medical Sciences, New Delhi, India. 2Department of Cardiac Anaesthesia, All India Institute of Medical Sciences, New Delhi, India. 3Department of Cardiac Radiology ,All India Institute of Medical Sciences, New Delhi, India. 4Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India. Article Info Article Notes Received: May 04, 2020 Accepted: June 13, 2020 *Correspondence: Dr. Ujjwal Kumar Chowdhury, M.Ch, Diplomate NB, Professor, Department of Cardiothoracic and Vascular Surgery, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029, India; Telephone No: 91-11-26594835; Fax No: 91-11- 26588663, 26588641; Email: [email protected], [email protected]; Orcid ID: http://orcid.org/0000-0002-1672-1502. ©2020 Chowdhury UK. This article is distributed under the terms of the Creative Commons Attribution
    [Show full text]
  • Ascending Aortic Disease in a Patient with Marfan Syndrome
    Case reports 2017; 3(2) https://doi.org/10.15446/cr.v3n2.61493 ASCENDING AORTIC DISEASE IN A PATIENT WITH MARFAN SYNDROME Palabras clave: Aneurisma de la Aorta; Cirugía torácica; Aorta Torácica; Disección aórtica aguda, Marfan. Keywords: Aortic Aneurysm; Thoracic surgery; Thoracic aorta; Acute Aortic Dissection, Marfan. Edison Ricardo Espinoza Saquicela General Surgeon Cardiothoracic Surgery resident Instituto Nacional de Cardiología Ignacio Chávez Universidad Nacional Autónoma de México Mexico City – México Stefanía del Cisne Serrano Olmedo General Surgeon Urology resident. Hospital Juárez de México Universidad Nacional Autónoma de México Mexico City - México Corresponding author: Edison Ricardo Espinoza Saquicela Instituto Nacional de Cardiología Ignacio Chávez Universidad Nacional Autónoma de México Ciudad de México. México Email: [email protected] Received: 10/12/2016 Accepted: 15/10/2017 ascending aortic disease in a patient with marfan syndrome ABSTRACT this condition, hence the importance of prop- 99 er diagnosis and management. Introduction. Acute thoracic aortic dissection is caused by a tear in the intimal lining of RESUMEN the aorta, and is a symptom of acute aortic syndrome. The dissection allows the blood to Introducción. La incidencia de síndrome de pass through the rupture and separates the tu- Marfan que ha sido reportada a nivel mundial nica intima from the tunica media or the tunica es de 1 en 5000 casos, de los cuales apro- adventitia, creating a false intravascular light. ximadamente el 80% o más desarrollan com- Early diagnosis directly affects the chances of plicaciones cardiovasculares. La disección survival, since it is a medical emergency that aórtica torácica aguda requiere una rotura en can lead to death, even with optimal treatment.
    [Show full text]
  • SPECIAL ISSUE Dear Colleagues
    INSIDE THIS ISSUE Bilateral Lung Tx ‘Hemi-Commando’ Branched Frozen Plus CABG for CAD for Bivalvular Elephant Trunk for with End-Stage Endocarditis – p. 6 Aortic Dissection Lung Disease – p. 4 – p. 8 Cardiac Consult Heart and Vascular News from Cleveland Clinic | Winter 2017 › SPECIAL ISSUE Dear Colleagues: If the past decade didn’t make it clear enough, 2016 has left no doubt: Continuing change is the surest constant we can count on in U.S. healthcare in the years ahead. The inevitability of that change is something we all must grapple with, par- ticularly when change increasingly comes in the form of tightening reimburse- ments. Those sorts of changes can make it all too tempting for organizations to hunker down and play it too safe, avoiding the most complex cases that might sometimes skew outcomes numbers or draw disproportionate staff time and resources. That’s a temptation Cleveland Clinic’s Miller Family Heart & Vascular Institute is Cardiac Consult offers updates and insights committed to never give in to. This special issue of Cardiac Consult is devoted from specialists in Cleveland Clinic’s Sydell exclusively to brief reports of complex cases managed at Cleveland Clinic in the and Arnold Miller Family Heart & Vascular past few years — years of unprecedented healthcare system change. Institute. Direct correspondence to: These case studies show how our institute’s interdisciplinary corps of clini- Medical Editors cians — cardiothoracic surgeons, vascular surgeons and all manner of cardio- Lars G. Svensson, MD, PhD vascular medicine subspecialists — pool their expertise in creative ways to Institute Chair solve problems for patients who’ve often been told elsewhere that their cases [email protected] are beyond intervention.
    [Show full text]
  • Cardiovascular/Thoracic Surgery CAQ Blueprint
    1 Cardiovascular/Thoracic Surgery CAQ Blueprint Content Area Percentage 1. Cardiac 40 2. Thoracic 15 3. Vascular 5 4. Assist Devices 5 5. ICU Management 15 6. Clinical Skill Requirements 5 7. Pharmacotherapy 10 8. Quality Metrics 5 The following clinical tasks apply to all categories below: – Patient presentation – Anatomy and physiology – Preoperative evaluation and management – Invasive and noninvasive imaging – Operative and non-operative intervention – Postoperative management 1. CARDIAC (40%) o Non–ST-segment elevation A. Aortic disease myocardial infarction • Aneurysm • Incomplete revascularization Root o • Prinzmetal variant angina Arch o • Post infarct complications Ascending o Dressler syndrome Pseudoaneurysm o o Left ventricular aneurysm • Aortic root disorders o Left ventricular wall rupture • o Connective tissue disorders Papillary muscle rupture • Dissection o o Ventricular septal defect B. Congenital conditions • Revascularization techniques and • Anomalous origin of the coronary artery conduits • Atrial septal defect • Coarctation of the aorta • Patent ductus arteriosus D. Electrophysiologic disorders • Patent foramen ovale • Atrial fibrillation/flutter • Persistent left superior vena cava • Blocks (atrioventricular, bundle branch, • Tetralogy of Fallot complete) • Ventricular septal defect • Bradycardia C. Coronary artery disease • Device-related infection • Acute coronary syndrome • Intraventricular conduction delay o Stable angina • Paroxysmal supraventricular tachycardia o Unstable angina • Tachycardia-bradycardia syndrome
    [Show full text]